| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794306 | Ophthalmology | 2017 | 11 Pages |
Abstract
The subretinal fluid foci associated with MEK inhibitors have unique clinical and morphologic characteristics, which can be distinguished from the findings of central serous chorioretinopathy. In this series, MEK inhibitors did not cause irreversible loss of vision or serious eye damage.
Keywords
CSCCSRinterdigitation zoneRPEPEDBCVAMAPKretinal pigment epitheliumOctbest-corrected visual acuityOptical coherence tomographyPigment epithelial detachmentCentral serous retinopathyMEKellipsoid zonemitogen-activated protein kinasemitogen-activated protein kinase kinaseCentral serous chorioretinopathy
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jasmine H. MD, FACS, Larissa A. MD, David H. MD, FACS, Lawrence A. MD, Murk MD, Mrinal M. MD, Rachel N. MD, Michael A. MD, Alexander N. MD, Ping MD, PhD, Neil H. MD, PhD, Rona MD, Alan L. MD, PhD, Paul B. MD, Federica PhD,